Scientists Find Clue to Lower Dementia Risk in Older Adults Through New ‘Game-Changer’ Vaccine

New Research Links Shingrix Vaccine to Lower Dementia Risk in Older Adults

Scientists have uncovered a potentially important clue in the fight against dementia after a large-scale study found that older adults who received the Shingrix shingles vaccine had a lower rate of dementia diagnoses than those who were not vaccinated.

The research, involving more than 500,000 older adults, found that people who received at least one dose of the recombinant zoster vaccine, commonly known as Shingrix, had an approximately 24% lower risk of receiving a dementia diagnosis over four years compared with similar people who remained unvaccinated.

The findings add to a growing body of research suggesting that vaccines may have benefits beyond protecting people from the infections they were originally designed to prevent.

What Did Scientists Discover?

Researchers examined health records involving 509,926 older adults who had recently stayed in skilled-nursing facilities. The study compared people who received the recombinant shingles vaccine with those who did not.

After four years, dementia was diagnosed in about 18.8% of vaccinated participants, compared with 24.6% among unvaccinated participants. Researchers calculated that this represented about a 24% lower relative risk of dementia among those who received the vaccine.

The difference is particularly interesting because dementia remains one of the biggest health challenges facing older populations around the world.

Why Could a Shingles Vaccine Affect Dementia?

Scientists are still working to understand the biological explanation.

Shingles is caused by the varicella-zoster virus, the same virus responsible for chickenpox. The virus can remain dormant in the nervous system and reactivate later in life.

One possibility is that preventing or reducing viral reactivation could also reduce processes that may contribute to inflammation or neurological damage. However, researchers stress that this is still an area of investigation rather than an established explanation.

The new findings therefore do not mean that Shingrix is currently proven to prevent dementia.

A Growing Pattern in Research

The latest study is not the first research to report a possible connection between shingles vaccination and reduced dementia risk.

Earlier studies have also observed lower dementia rates among people who received shingles vaccines. For example, research published in 2025 found an association between shingles vaccination and approximately a 20% lower relative risk of dementia over seven years in a Welsh population.

Together, these findings have encouraged researchers to investigate whether vaccination could play a role in protecting brain health.

Researchers Warn That More Studies Are Needed

Despite the encouraging results, scientists are careful not to describe the vaccine as a proven dementia-prevention treatment.

People who receive vaccines can differ from unvaccinated people in important ways, including age, health status, healthcare access and other lifestyle factors. Researchers attempted to account for some of these differences, but observational health-record studies cannot completely eliminate every possible source of bias.

The researchers say randomized clinical trials would be needed to determine whether the vaccine itself directly reduces dementia risk.

What Does This Mean for Older Adults?

The findings could eventually become important for public health if future research confirms a protective effect.

For now, however, people should not receive Shingrix specifically as a treatment for dementia. The vaccine is used to protect against shingles and its complications.

The potential connection with dementia is an additional research finding that scientists are continuing to investigate.

Why Scientists Are Calling It a Potential ‘Game-Changer’

Dementia affects millions of people worldwide and can have profound consequences for patients, families and caregivers.

A relatively straightforward preventive intervention that could potentially reduce dementia risk would therefore have enormous public-health implications.

If future clinical research confirms the relationship, vaccination could become part of a broader strategy for protecting health in older age.

For now, scientists describe the latest findings as an important clue rather than a final answer.

Bottom Line

The latest evidence suggests that older adults who received the Shingrix shingles vaccine were about 24% less likely to be diagnosed with dementia over four years in this large health-record study. However, researchers have not yet proved that the vaccine itself prevents dementia.

More rigorous clinical research will be needed before scientists can determine whether the shingles vaccine truly has a protective effect on the aging brain.